表紙
市場調查報告書

心臟麻痺治療市場(不同治療:醫藥品及醫療設備,銷售管道:醫院,獨立型藥局) - 全球產業分析,規模,佔有率,成長,趨勢,及預測 2019年 - 2027年

Cardiac Arrest Treatment Market (Treatment - Drugs and Medical Devices; Sales Channel - Hospitals, Independent Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

出版商 Transparency Market Research 商品編碼 881227
出版日期 內容資訊 英文 220 Pages
商品交期: 最快1-2個工作天內
價格
心臟麻痺治療市場(不同治療:醫藥品及醫療設備,銷售管道:醫院,獨立型藥局) - 全球產業分析,規模,佔有率,成長,趨勢,及預測 2019年 - 2027年 Cardiac Arrest Treatment Market (Treatment - Drugs and Medical Devices; Sales Channel - Hospitals, Independent Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027
出版日期: 2019年05月14日內容資訊: 英文 220 Pages
簡介

這份報告提供全球心臟麻痺治療市場的相關調查,提供市場趨勢和機會,成長和阻礙因素,治療·銷售管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 報告範圍和市場區隔
  • 研究亮點

第2章 假設和調查方法

  • 所使用的前提和簡稱
  • 調查方法

第3章 摘要整理

第4章 市場概要

  • 治療概要
  • 主要產業的發展
  • 市場趨勢
  • 成長要素·阻礙因素的概述分析
  • 成長要素
    • 鬱血性心衰竭(CHF)的罹患率的上升
    • 政府的配合措施
  • 阻礙因素
    • 新興國家的心臟麻痺治療的有效性低
    • 學名藥產業的成長
  • 市場機會
  • 市場收益預測(100萬美元)2017年∼2027年

第5章 主要洞察

  • 主要國家的心臟麻痺的發生率
  • 治療心臟麻痺的醫療設備之技術進步
  • 治療使用模式(心臟麻痺的三相模式)
  • 臨床開發的有潛力治療方法:心臟麻痺
  • 用於治療OHCA的每位患者的院前設備的年度費用
  • 主要的合併和收購
  • 主要企業的研究開發策略
  • 心臟麻痺治療藥的開發平台分析

第6章 全球心臟麻痺治療市場分析:不同治療

  • 簡介
  • 市場規模及預測
    • 藥物
    • 醫療設備
  • 市場分析
  • 市場魅力分析

第7章 全球心臟麻痺治療市場分析:各銷售管道

  • 簡介
  • 市場規模及預測
    • 醫院
    • 獨立藥局
    • 其他
  • 市場分析
  • 市場魅力分析

第8章 全球心臟麻痺治療市場分析:各地區

  • 市場規模及預測 2017年∼2027年
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東及非洲
  • 市場分析
  • 市場魅力分析

第9章 北美

第10章 歐洲

第11章 亞太地區

第12章 南美

第13章 中東及非洲

第14章 競爭情形

  • 企業簡介
    • Amgen, Inc.
    • Pfizer, Inc.
    • Johnson & Johnson
    • Novartis AG
    • Bristol-Myers Squibb Company
    • Abbott
    • Bayer AG
    • Koninklijke Philips NV
    • GE Healthcare
    • Physio-Control, Inc. (Stryker)
    • Boston Scientific Corporation
    • Cardiac Science Corporation (Aurora Capital Group)
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
目錄

Cardiac Arrest Treatment Market - Overview

This report analyzes the current and future scenario of the global cardiac arrest treatment market. Cardiac resynchronization therapy (CRT) has been considered the standard and most effective form of first aid in case of a sudden cardiac arrest and has been taught in classrooms and community centers across the world. Despite such popularity and awareness, CRT alone cannot save sudden cardiac arrest (SCA) victims. Majority of the people who experience sudden cardiac arrest have ventricular fibrillation (VF) which causes the heart muscles to beat rapidly and improperly in which CRT alone cannot provide effective results. The global cardiac arrest treatment market is driven by rise in chronic heart health conditions, increase in geriatric and overall population with cardiovascular disorders.

The global cardiac arrest treatment market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment, sales channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global cardiac arrest treatment market.

Global Cardiac Arrest Treatment Market: Key Segments

In terms of treatment, the global cardiac arrest treatment market has been segmented into drugs and medical devices. The drugs segment has been categorized into vasopressors, anti-arrhythmic drugs, anticholinergic drugs, corticosteroids, fibrinolytic drugs, beta blockers, and others (sodium bicarbonate, crystalloids, colloids, etc.). The medical devices segment has been classified into defibrillators, cardiac resynchronization therapy (CRT), and others. In terms of sales channel, the global cardiac arrest treatment market has been divided into hospitals, independent pharmacies, and others. The market size and forecast for each of these segments have been provided in terms of US$ Mn for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year.

Global Cardiac Arrest Treatment Market: Regional Outlook

Geographically, the global cardiac arrest treatment market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global cardiac arrest treatment market based on various attributes such as company overview, financial overview, treatment portfolio, business strategies, and recent developments. These are Amgen, Inc., Pfizer, Inc., Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Abbott, Bayer AG, Koninklijke Philips N.V., GE Healthcare, Physio-Control, Inc. (Stryker), Boston Scientific Corporation, Cardiac Science Corporation (Aurora Capital Group), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

The global cardiac arrest treatment market has been segmented as below:

  • Global Cardiac Arrest Treatment Market, by Treatment
  • Drugs
  • Vasopressors
  • Anti-arrhythmic Drugs
  • Anticholinergic Drugs
  • Corticosteroids
  • Fibrinolytic Drugs
  • Beta Blockers
  • Others (sodium bicarbonate, crystalloids, colloids, etc.)
  • Medical Devices
  • Defibrillators
  • Cardiac Resynchronization Therapy (CRT)
  • Others
  • Global Cardiac Arrest Treatment Market, by Sales Channel
  • Hospitals
  • Independent Pharmacies
  • Others
  • Global Cardiac Arrest Treatment Market, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

3. Executive Summary

  • 3.1. Global Cardiac Arrest Treatment Market Size (US$ Mn) and Distribution, by Region, 2019 and 2027
  • 3.2. Global Cardiac Arrest Treatment Market: Market Snapshot

4. Market Overview

  • 4.1. Global Cardiac Arrest Treatment Market: Treatment Overview
  • 4.2. Global Cardiac Arrest Treatment Market: Key Industry Developments
  • 4.3. Market Dynamics
  • 4.4. Drivers and Restraints Snapshot Analysis
  • 4.5. Drivers
    • 4.5.1. Rise in prevalence of congestive heart failure (CHF)
    • 4.5.2. Government initiatives
  • 4.6. Restraints
    • 4.6.1. Low availability of cardiac arrest treatment in emerging countries
    • 4.6.2. Growth of the generic drugs industry
  • 4.7. Opportunities
  • 4.8. Global Cardiac Arrest Treatment Market Revenue Projections (US$ Mn), 2017-2027

5. Key Insights

  • 5.1. Incidence Rate of Cardiac Arrest In Key Countries
  • 5.2. Technological Advancements in Medical Devices for Cardiac Arrest Treatment
  • 5.3. Treatment Usage Pattern (Three-Phase Model of Cardiac Arrest)
  • 5.4. Promising Treatments in Clinical Development: Cardiac Arrest
  • 5.5. Annual cost of prehospital equipment per patient used to treat OHCA (Out- of Hospital Cardiac Arrest)
  • 5.6. Key Merger and Acquisition
  • 5.7. Research and Development Strategies for Key Companies
  • 5.8. Pipeline Analysis for Cardiac Arrest Therapeutics

6. Global Cardiac Arrest Treatment Market Analysis, by Treatment

  • 6.1. Introduction
  • 6.2. Global Cardiac Arrest Treatment Market Size and Forecast, by Treatment
    • 6.2.1. Drugs
      • 6.2.1.1. Vasopressors
      • 6.2.1.2. Anti-arrhythmic Drugs
      • 6.2.1.3. Anticholinergic Drugs
      • 6.2.1.4. Corticosteroids
      • 6.2.1.5. Fibrinolytic Drugs
      • 6.2.1.6. Beta Blockers
      • 6.2.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
    • 6.2.2. Medical Devices
      • 6.2.2.1. Defibrillators
      • 6.2.2.2. Cardiac Resynchronization Therapy (CRT)
      • 6.2.2.3. Others
  • 6.3. Global Cardiac Arrest Treatment Market Analysis, by Treatment
  • 6.4. Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Treatment

7. Global Cardiac Arrest Treatment Market Analysis, by Sales Channel

  • 7.1. Introduction
  • 7.2. Global Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel
    • 7.2.1. Hospitals
    • 7.2.2. Independent Pharmacies
    • 7.2.3. Others
  • 7.3. Global Cardiac Arrest Treatment Market Analysis, by Sales Channel
  • 7.4. Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Sales Channel

8. Global Cardiac Arrest Treatment Market Analysis, by Region

  • 8.1. Global Cardiac Arrest Treatment Market Size and Forecast, by Region, 2017-2027
    • 8.1.1. North America
    • 8.1.2. Europe
    • 8.1.3. Asia Pacific
    • 8.1.4. Latin America
    • 8.1.5. Middle East & Africa
  • 8.2. Global Cardiac Arrest Treatment Market Analysis, by Region
  • 8.3. Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Region

9. North America Cardiac Arrest Treatment Market Analysis

  • 9.1. North America Cardiac Arrest Treatment Market
  • 9.2. North America Cardiac Arrest Treatment Market Overview
  • 9.3. North America Cardiac Arrest Treatment Market Size and Forecast, by Treatment
    • 9.3.1. Drugs
      • 9.3.1.1. Vasopressors
      • 9.3.1.2. Anti-arrhythmic Drugs
      • 9.3.1.3. Anticholinergic Drugs
      • 9.3.1.4. Corticosteroids
      • 9.3.1.5. Fibrinolytic Drugs
      • 9.3.1.6. Beta Blockers
      • 9.3.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
    • 9.3.2. Medical Devices
      • 9.3.2.1. Defibrillators
      • 9.3.2.2. Cardiac Resynchronization Therapy (CRT)
      • 9.3.2.3. Others
  • 9.4. North America Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel
    • 9.4.1. Hospitals
    • 9.4.2. Independent Pharmacies
    • 9.4.3. Others
  • 9.5. North America Cardiac Arrest Treatment Market Forecast, by Country
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. North America Cardiac Arrest Treatment Market Attractiveness Analysis
    • 9.6.1. By Treatment
    • 9.6.2. By Sales Channel
    • 9.6.3. By Country

10. Europe Cardiac Arrest Treatment Market Analysis

  • 10.1. Europe Cardiac Arrest Treatment Market
  • 10.2. Europe Cardiac Arrest Treatment Market Overview
  • 10.3. Europe Cardiac Arrest Treatment Market Size and Forecast, by Treatment
    • 10.3.1. Drugs
      • 10.3.1.1. Vasopressors
      • 10.3.1.2. Anti-arrhythmic Drugs
      • 10.3.1.3. Anticholinergic Drugs
      • 10.3.1.4. Corticosteroids
      • 10.3.1.5. Fibrinolytic Drugs
      • 10.3.1.6. Beta Blockers
      • 10.3.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
    • 10.3.2. Medical Devices
      • 10.3.2.1. Defibrillators
      • 10.3.2.2. Cardiac Resynchronization Therapy (CRT)
      • 10.3.2.3. Others
  • 10.4. Europe Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel
    • 10.4.1. Hospitals
    • 10.4.2. Independent Pharmacies
    • 10.4.3. Others
  • 10.5. Europe Cardiac Arrest Treatment Market Forecast, by Country/Sub-region
    • 10.5.1. U.K.
    • 10.5.2. France
    • 10.5.3. Germany
    • 10.5.4. Spain
    • 10.5.5. Italy
    • 10.5.6. Rest of Europe
  • 10.6. Europe Cardiac Arrest Treatment Market Attractiveness Analysis
    • 10.6.1. By Treatment
    • 10.6.2. By Sales Channel
    • 10.6.3. By Country/Sub-region

11. Asia Pacific Cardiac Arrest Treatment Market Analysis

  • 11.1. Asia Pacific Cardiac Arrest Treatment Market Key Findings
  • 11.2. Asia Pacific Cardiac Arrest Treatment Market Overview
  • 11.3. Asia Pacific Cardiac Arrest Treatment Market Size and Forecast, by Treatment
    • 11.3.1. Drugs
      • 11.3.1.1. Vasopressors
      • 11.3.1.2. Anti-arrhythmic Drugs
      • 11.3.1.3. Anticholinergic Drugs
      • 11.3.1.4. Corticosteroids
      • 11.3.1.5. Fibrinolytic Drugs
      • 11.3.1.6. Beta Blockers
      • 11.3.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
    • 11.3.2. Medical Devices
      • 11.3.2.1. Defibrillators
      • 11.3.2.2. Cardiac Resynchronization Therapy (CRT)
      • 11.3.2.3. Others
  • 11.4. Asia Pacific Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel
    • 11.4.1. Hospitals
    • 11.4.2. Independent Pharmacies
    • 11.4.3. Others
  • 11.5. Asia Pacific Cardiac Arrest Treatment Market Forecast, by Country/Sub-region
    • 11.5.1. China
    • 11.5.2. India
    • 11.5.3. Japan
    • 11.5.4. Australia & New Zealand
    • 11.5.5. Rest of Asia Pacific
  • 11.6. Asia Pacific Cardiac Arrest Treatment Market Attractiveness Analysis
    • 11.6.1. By Treatment
    • 11.6.2. By Sales Channel
    • 11.6.3. By Country/Sub-region

12. Latin America Cardiac Arrest Treatment Market Analysis

  • 12.1. Latin America Cardiac Arrest Treatment Market Key Findings
  • 12.2. Latin America Cardiac Arrest Treatment Market Overview
  • 12.3. Latin America Cardiac Arrest Treatment Market Size and Forecast, by Treatment
    • 12.3.1. Drugs
      • 12.3.1.1. Vasopressors
      • 12.3.1.2. Anti-arrhythmic Drugs
      • 12.3.1.3. Anticholinergic Drugs
      • 12.3.1.4. Corticosteroids
      • 12.3.1.5. Fibrinolytic Drugs
      • 12.3.1.6. Beta Blockers
      • 12.3.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
    • 12.3.2. Medical Devices
      • 12.3.2.1. Defibrillators
      • 12.3.2.2. Cardiac Resynchronization Therapy (CRT)
      • 12.3.2.3. Others
  • 12.4. Latin America Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel
    • 12.4.1. Hospitals
    • 12.4.2. Independent Pharmacies
    • 12.4.3. Others
  • 12.5. Latin America Cardiac Arrest Treatment Market Forecast, by Country/Sub-region
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Latin America Cardiac Arrest Treatment Market Attractiveness Analysis
    • 12.6.1. By Treatment
    • 12.6.2. By Sales Channel
    • 12.6.3. By Country/Sub-region

13. Middle East & Africa Cardiac Arrest Treatment Market Analysis

  • 13.1. Middle East & Africa Cardiac Arrest Treatment Market
  • 13.2. Middle East & Africa Cardiac Arrest Treatment Market Overview
  • 13.3. Middle East & Africa Cardiac Arrest Treatment Market Size and Forecast, by Treatment
    • 13.3.1. Drugs
      • 13.3.1.1. Vasopressors
      • 13.3.1.2. Anti-arrhythmic Drugs
      • 13.3.1.3. Anticholinergic Drugs
      • 13.3.1.4. Corticosteroids
      • 13.3.1.5. Fibrinolytic Drugs
      • 13.3.1.6. Beta Blockers
      • 13.3.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
    • 13.3.2. Medical Devices
      • 13.3.2.1. Defibrillators
      • 13.3.2.2. Cardiac Resynchronization Therapy (CRT)
      • 13.3.2.3. Others
  • 13.4. Middle East & Africa Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel
    • 13.4.1. Hospitals
    • 13.4.2. Independent Pharmacies
    • 13.4.3. Others
  • 13.5. Middle East & Africa Cardiac Arrest Treatment Market Forecast, by Country/Sub-region
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. Rest of Middle East & Africa
  • 13.6. Middle East & Africa Cardiac Arrest Treatment Market Attractiveness Analysis
    • 13.6.1. By Treatment
    • 13.6.2. By Sales Channel
    • 13.6.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Company Profiles
    • 14.1.1. Amgen, Inc.
      • 14.1.1.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.1.2. Financials
      • 14.1.1.3. Recent Developments
      • 14.1.1.4. Strategy
    • 14.1.2. Pfizer, Inc.
      • 14.1.2.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.2.2. Financials
      • 14.1.2.3. Recent Developments
      • 14.1.2.4. Strategy
    • 14.1.3. Johnson & Johnson
      • 14.1.3.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.3.2. Financials
      • 14.1.3.3. Recent Developments
      • 14.1.3.4. Strategy
    • 14.1.4. Novartis AG
      • 14.1.4.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.4.2. Financials
      • 14.1.4.3. Recent Developments
      • 14.1.4.4. Strategy
    • 14.1.5. Bristol-Myers Squibb Company
      • 14.1.5.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.5.2. Financials
      • 14.1.5.3. Recent Developments
      • 14.1.5.4. Strategy
    • 14.1.6. Abbott
      • 14.1.6.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.6.2. Financials
      • 14.1.6.3. Recent Developments
      • 14.1.6.4. Strategy
    • 14.1.7. Bayer AG
      • 14.1.7.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.7.2. Financials
      • 14.1.7.3. Recent Developments
      • 14.1.7.4. Strategy
    • 14.1.8. Koninklijke Philips N.V
      • 14.1.8.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.8.2. Financials
      • 14.1.8.3. Recent Developments
      • 14.1.8.4. Strategy
    • 14.1.9. GE Healthcare
      • 14.1.9.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.9.2. Financials
      • 14.1.9.3. Recent Developments
      • 14.1.9.4. Strategy
    • 14.1.10. Physio-Control, Inc. (Stryker)
      • 14.1.10.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.10.2. Financials
      • 14.1.10.3. Recent Developments
      • 14.1.10.4. Strategy
    • 14.1.11. Boston Scientific Corporation
      • 14.1.11.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.11.2. Financials
      • 14.1.11.3. Recent Developments
      • 14.1.11.4. Strategy
    • 14.1.12. Cardiac Science Corporation (Aurora Capital Group)
      • 14.1.12.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.12.2. Financials
      • 14.1.12.3. Recent Developments
      • 14.1.12.4. Strategy
    • 14.1.13. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
      • 14.1.13.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.1.13.2. Financials
      • 14.1.13.3. Recent Developments
      • 14.1.13.4. Strategy

List of Tables

  • TABLE 1 Prevalence Rate of Cardiac Arrest In Key Countries
  • TABLE 2 Promising Treatments in Clinical Development: Cardiac Arrest, by Phase 2 Drugs
  • TABLE 3 Promising Treatments in Clinical Development: Cardiac Arrest, by Phase 3 and Phase 4 Drugs
  • TABLE 4 Annual cost of prehospital equipment per patient used to treat OHCA (Out- of Hospital Cardiac Arrest)
  • TABLE 5 Cost incurred to cardiac arrest patients
  • TABLE 6 Key Merger and Acquisition (1/2)
  • TABLE 7 Key Merger and Acquisition (2/2)
  • TABLE 8 Percent of Heart Failure Trials, by Phase and Location
  • TABLE 9 Percent of Heart Failure Trials, by Phase and Companies
  • TABLE 10 Pipeline Analysis for Cardiovascular Disorders Therapeutics (1/5)
  • TABLE 11 Pipeline Analysis for Cardiovascular Disorders Therapeutics (2/5)
  • TABLE 12 Pipeline Analysis for Cardiovascular Disorders Therapeutics (3/5)
  • TABLE 13 Pipeline Analysis for Cardiovascular Disorders Therapeutics (4/5)
  • TABLE 14 Pipeline Analysis for Cardiovascular Disorders Therapeutics (5/5)
  • TABLE 15 Global Cardiac Arrest Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017-2027
  • TABLE 16 Global Cardiac Arrest Treatment Market Size (US$ Mn) Forecast, by Drugs, 2017-2027
  • TABLE 17 Global Cardiac Arrest Treatment Market Size (US$ Mn) Forecast, by Medical Devices, 2017-2027
  • TABLE 18 Global Cardiac Arrest Treatment Market Size (US$ Mn) Forecast, by Sales Channel, 2017-2027
  • TABLE 19 Global Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • TABLE 20 North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • TABLE 21 North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • TABLE 22 North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Drugs, 2017-2027
  • TABLE 23 North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Medical Devices, 2017-2027
  • TABLE 24 North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017-2027
  • TABLE 25 Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • TABLE 26 Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • TABLE 27 Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Drugs, 2017-2027
  • TABLE 28 Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Medical Devices, 2017-2027
  • TABLE 29 Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017-2027
  • TABLE 30 Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • TABLE 31 Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • TABLE 32 Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Drugs, 2017-2027
  • TABLE 33 Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Medical Devices, 2017-2027
  • TABLE 34 Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017-2027
  • TABLE 35 Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • TABLE 36 Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • TABLE 37 Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Drugs, 2017-2027
  • TABLE 38 Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Medical Devices, 2017-2027
  • TABLE 39 Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017-2027
  • TABLE 40 Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • TABLE 41 Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • TABLE 42 Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Drugs, 2017-2027
  • TABLE 43 Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Medical Devices, 2017-2027
  • TABLE 44 Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, by Sales Channel, 2017-2027

List of Figures

  • FIG. 1 Global Cardiac Arrest Treatment Market Size (US$ Mn), 2017 and 2026
  • FIG. 2 Global Cardiac Arrest Treatment Market Snapshot
  • FIG. 3 Global Cardiac Arrest Treatment Market Size (US$ Mn) Forecast, 2017-2027
  • FIG. 4 Global Cardiac Arrest Treatment Market
  • FIG. 5 Global Cardiac Arrest Treatment Market
  • FIG. 6 Global Cardiac Arrest Treatment Market
  • FIG. 7 Global Cardiac Arrest Treatment Market
  • FIG. 8 Global Cardiac Arrest Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • FIG. 9 Global Cardiac Arrest Treatment Market Value Share Analysis, by Drugs, 2018 and 2027
  • FIG. 10 Global Cardiac Arrest Treatment Market Value Share Analysis, by Medical Devices, 2018 and 2027
  • FIG. 11 Global Cardiac Arrest Treatment Market Revenue (US$ Mn) Forecast, by Vasopressors, 2017-2027
  • FIG. 12 Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Anti-arrhythmic Drugs, 2017-2027
  • FIG. 13 Global Cardiac Arrest Treatment Market Revenue (US$ Mn) Forecast, by Anticholinergic Drugs, 2017-2027
  • FIG. 14 Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Corticosteroids, 2017-2027
  • FIG. 15 Global Cardiac Arrest Treatment Market Revenue (US$ Mn) Forecast, by Fibrinolytic Drugs, 2017-2027
  • FIG. 16 Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Beta Blockers, 2017-2027
  • FIG. 17 Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Others, 2017-2027
  • FIG. 18 Global Cardiac Arrest Treatment Market Revenue (US$ Mn) Forecast, by Defibrillators, 2017-2027
  • FIG. 19 Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Cardiac Resynchronization Therapy (CRT), 2017-2027
  • FIG. 20 Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Others, 2017-2027
  • FIG. 21 Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Drugs, 2017-2025
  • FIG. 22 Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Medical Devices, 2017-2025
  • FIG. 23 Global Cardiac Arrest Treatment Market Value Share Analysis, by Sales Channel, 2017 and 2025
  • FIG. 24 Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Hospital, 2017-2027
  • FIG. 25 Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Independent Pharmacies, 2017-2027
  • FIG. 26 Global Cardiac Arrest Treatment Market Revenue (US$ Mn), by Others, 2017-2027
  • FIG. 27 Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Sales Channel 2017-2025
  • FIG. 28 Global Cardiac Arrest Treatment Market Value Share, by Region, 2018 and 2027
  • FIG. 29 Global Cardiac Arrest Treatment Market Attractiveness, by Region, 2019-2027
  • FIG. 30 North America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, 2019-2027
  • FIG. 31 North America Cardiac Arrest Treatment Market Value Share, by Country, 2018 and 2027
  • FIG. 32 North America Cardiac Arrest Treatment Market Attractiveness, by Country, 2019-2027
  • FIG. 33 North America Cardiac Arrest Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • FIG. 34 North America Cardiac Arrest Treatment Market Attractiveness, by Treatment, 2019-2027
  • FIG. 35 North America Cardiac Arrest Treatment Market Value Share Analysis, by Drugs, 2018 and 2027
  • FIG. 36 North America Cardiac Arrest Treatment Market Value Share Analysis, by Medical Devices, 2018 and 2027
  • FIG. 37 North America Cardiac Arrest Treatment Market Value Share Analysis, by Sales Channel, 2018 and 2027
  • FIG. 38 North America Cardiac Arrest Treatment Market Attractiveness, by Sales Channel, 2019-2027
  • FIG. 39 Europe Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, 2017-2027
  • FIG. 40 Europe Cardiac Arrest Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • FIG. 41 Europe Cardiac Arrest Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • FIG. 42 Europe Cardiac Arrest Treatment Market Value Share, by Treatment, 2018 and 2027
  • FIG. 43 Europe Cardiac Arrest Treatment Market Attractiveness, by Treatment, 2019-2027
  • FIG. 44 Europe Cardiac Arrest Treatment Market Value Share, by Drugs, 2018 and 2027
  • FIG. 45 Europe Cardiac Arrest Treatment Market Value Share, by Medical Devices, 2018 and 2027
  • FIG. 46 Europe Cardiac Arrest Treatment Market Value Share, by Sales Channel, 2018 and 2027
  • FIG. 47 Europe Cardiac Arrest Treatment Market Attractiveness, by Sales Channel, 2019-2027
  • FIG. 48 Asia Pacific Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, 2019-2027
  • FIG. 49 Asia Pacific Cardiac Arrest Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • FIG. 50 Asia Pacific Cardiac Arrest Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • FIG. 51 Asia Pacific Cardiac Arrest Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • FIG. 52 Asia Pacific Cardiac Arrest Treatment Market Attractiveness, by Treatment, 2019-2027
  • FIG. 53 Asia Pacific Cardiac Arrest Treatment Market Value Share Analysis, by Drugs, 2018 and 2027
  • FIG. 54 Asia Pacific Cardiac Arrest Treatment Market Value Share Analysis, by Medical Devices, 2018 and 2027
  • FIG. 55 Asia Pacific Cardiac Arrest Treatment Market Value Share Analysis, by Sales Channel, 2018 and 2027
  • FIG. 56 Asia Pacific Cardiac Arrest Treatment Market Attractiveness, by Sales Channel, 2019-2027
  • FIG. 57 Latin America Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, 2017-2027
  • FIG. 58 Latin America Cardiac Arrest Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • FIG. 59 Latin America Cardiac Arrest Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • FIG. 60 Latin America Cardiac Arrest Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • FIG. 61 Latin America Cardiac Arrest Treatment Market Attractiveness, by Treatment, 2019-2027
  • FIG. 62 Latin America Cardiac Arrest Treatment Market Value Share Analysis, by Drugs, 2018 and 2027
  • FIG. 63 Latin America Cardiac Arrest Treatment Market Value Share Analysis, by Medical Devices, 2018 and 2027
  • FIG. 64 Latin America Cardiac Arrest Treatment Market Value Share Analysis, by Sales Channel, 2018 and 2027
  • FIG. 65 Latin America Cardiac Arrest Treatment Market Attractiveness, by Sales Channel, 2019-2027
  • FIG. 66 Middle East & Africa Cardiac Arrest Treatment Market Value (US$ Mn) Forecast, 2017-2027
  • FIG. 67 Middle East & Africa Cardiac Arrest Treatment Market Value Share, by Country/Sub-region, 2018 and 2027
  • FIG. 68 Middle East & Africa Cardiac Arrest Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • FIG. 69 Middle East & Africa Cardiac Arrest Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • FIG. 70 Middle East & Africa Cardiac Arrest Treatment Market Attractiveness, by Treatment, 2019-2027
  • FIG. 71 Middle East & Africa Cardiac Arrest Treatment Market Value Share Analysis, by Drugs, 2018 and 2027
  • FIG. 72 Middle East & Africa Cardiac Arrest Treatment Market Value Share Analysis, by Medical Devices, 2018 and 2027
  • FIG. 73 Middle East & Africa Cardiac Arrest Treatment Market Value Share Analysis, by Sales Channel, 2018 and 2027
  • FIG. 74 Middle East & Africa Cardiac Arrest Treatment Market Attractiveness, by Sales Channel, 2019-2027
  • FIG. 75 Global Cardiac Arrest Treatment Drugs Market Share Analysis, by Company (2018)
  • FIG. 76 Global Cardiac Arrest Treatment Medical Devices Market Share Analysis, by Company (2018)